Full name: Leila Dehghani
Educational background and field of study: PhD. in Applied Cell Sciences
Performer of tests: Sequencing, MTT, Scratch Test, and Adhesion
Lab: Cell Culture Lab, Molecular Lab
email address: l_dehghani2002@yahoo.com
Selected scholarly articles:
- Safety of intraparenchymal injection of allogenic placenta mesenchymal stem cells derived exosome in patients undergoing decompressive craniectomy following malignant middle cerebral artery infarct, a pilot randomized clinical trial. Dehghani L, Khojasteh A, Soleimani M, Oraee-Yazdani S, Keshel SH, Saadatnia M, Saboori M, Zali A, Hashemi SM, Soleimani R. International Journal of Preventive Medicine. 2022 Jan 1;13(1):7.
- Ermin deficiency leads to compromised myelin, inflammatory milieu, and susceptibility to demyelinating insult. Ziaei A, Garcia‐Miralles M, Radulescu CI, Sidik H, Silvin A, Bae HG, Bonnard C, Yusof NA, Ferrari Bardile C, Tan LJ, Dehghani L, Ng AY. Brain Pathology. 2022 Mar 13:e13064.
- A systematic review of extracellular vesicles as non-invasive biomarkers in glioma diagnosis, prognosis, and treatment response monitoring. Sourani, A., Saghaei, S., Sabouri, Dehghani, L. Mol Biol Rep (2021).
- Stem Cell-Derived Exosomes as Treatment for Stroke: a Systematic Review. Dehghani L, Khojasteh A, Oraee Yazdani S, Soleimani M, et al. Stem Cell Rev Rep. 2020 Sep 15.
- Role of mesenchymal stem cells derived exosomes therapy in neuronal remodeling after ischemic stroke. Dehghani L, Khojasteh A, Oraee Yazdani S, Oustad M, Soleimani M. Minerva Med. 2019 Oct 14.